Product Theater:
Lexeo Therapeutics
WHEN: Sun, Oct 25 // 7:00 am - 8:00 am (ET)
IN-PERSON: Seaport Ballroom (Mezzanine / Level 2)
LIVESTREAM: Yes | ON-DEMAND: No
Hot breakfast options served in addition to Summit main fare.
Download Slides
Missed it live? Lexeo is sharing its presentation slides in place of a recording:
All Hypertrophy is Familiar, Until It Isn't: Friedreich Ataxia Cardiomyopathy & Addressing the Root Cause with AAV Gene Therapy
Friedreich ataxia cardiomyopathy (FA-CM) often presents with left ventricular hypertrophy familiar to HCM specialists, yet differs substantially in its underlying biology, disease trajectory, and unmet clinical needs. This product theater will explore FA-CM and discuss Lexeo's investigational adeno-associated virus (AAV) gene therapy program (LX2006) designed to target the root cause of the disease.
Speaker:
Jennifer White, DHSc, CCP, MS
Lexeo Therapeutics
BACK TO MAIN PRODUCT THEATERS PAGE